Trial intelligence / Profile preview

Clinical evaluation of 1.5% levofloxacin ophthalmic solution for preoperative ocular sterilization in cataract surgery

jRCT1080221649Phase 4

Sponsor
Santen Pharmaceutical
Start
Nov 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of levofloxacin in cataract and postoperative endophthalmitis, sponsored by Santen Pharmaceutical.

02

Drugs

levofloxacin
03

Conditions

cataractpostoperative endophthalmitis

Beyond the preview

Go deeper on jRCT1080221649.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080221649.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call